107 related articles for article (PubMed ID: 11367574)
21. Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression.
Anderson C; Hrabovsky S; McKinley Y; Tubesing K; Tang HP; Dunbar R; Mukhtar H; Elmets CA
Photochem Photobiol; 1997 May; 65(5):895-901. PubMed ID: 9155263
[TBL] [Abstract][Full Text] [Related]
22. Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model.
Li LB; Luo RC
Lasers Med Sci; 2009 Jul; 24(4):597-603. PubMed ID: 18936869
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
[TBL] [Abstract][Full Text] [Related]
24. Systemic immunosuppression induced by peritoneal photodynamic therapy.
Jolles CJ; Ott MJ; Straight RC; Lynch DH
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 1):1446-53. PubMed ID: 2968047
[TBL] [Abstract][Full Text] [Related]
25. Suppression of hapten-specific delayed-type hypersensitivity responses in mice by idiotype-specific suppressor T cells after administration of anti-idiotypic antibodies.
Yamamoto H; Nonaka M; Katz DH
J Exp Med; 1979 Oct; 150(4):818-29. PubMed ID: 92519
[TBL] [Abstract][Full Text] [Related]
26. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser.
Mori M; Sakata I; Hirano T; Obana A; Nakajima S; Hikida M; Kumagai T
Jpn J Cancer Res; 2000 Jul; 91(7):753-9. PubMed ID: 10920284
[TBL] [Abstract][Full Text] [Related]
28. Two phenotypically distinct T cells (Ly1+2- and Ly1-2+) are involved in ultraviolet-B light-induced suppression of the efferent DTH response to HSV-1 in vivo.
Howie SE; Norval M; Maingay J; Ross JA
Immunology; 1986 Aug; 58(4):653-8. PubMed ID: 3015783
[TBL] [Abstract][Full Text] [Related]
29. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors.
Cecic I; Parkins CS; Korbelik M
Photochem Photobiol; 2001 Nov; 74(5):712-20. PubMed ID: 11723800
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity.
Chabrier-Roselló Y; Foster TH; Pérez-Nazario N; Mitra S; Haidaris CG
Antimicrob Agents Chemother; 2005 Oct; 49(10):4288-95. PubMed ID: 16189110
[TBL] [Abstract][Full Text] [Related]
31. Systemic suppression of the contact hypersensitivity by the products of protoporphyrin IX photooxidation.
Kyagova AA; Mansurova GV; Kozir LA; Ponomarev GV; Pavlov VY; Konstantinov IO; Potapenko AY
Photochem Photobiol; 2005; 81(6):1380-5. PubMed ID: 16080780
[TBL] [Abstract][Full Text] [Related]
32. Distinction between suppressors of the delayed-type hypersensitivity and the humoral response to sheep erythrocytes.
Yamaguchi K; Kishimoto S
Immunology; 1978 Nov; 35(5):721-31. PubMed ID: 309853
[TBL] [Abstract][Full Text] [Related]
33. Thymocytes induced by antigen injection into the anterior chamber activate splenic CD8+ suppressor cells and enhance the antigen-induced production of immunoglobulin G1 antibodies.
Li X; Wang Y; Urso D; O'Rourke J; Cone RE
Immunology; 2004 Sep; 113(1):44-56. PubMed ID: 15312135
[TBL] [Abstract][Full Text] [Related]
34. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
[TBL] [Abstract][Full Text] [Related]
35. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity.
Ptak W; Bereta M; Ptak M; Askenase PW
J Immunol; 1986 Mar; 136(5):1554-63. PubMed ID: 2419404
[TBL] [Abstract][Full Text] [Related]
36. Impairment of allograft tumor immunity by isotype-like suppression of antigen-specific T cell factors.
Van Loveren H; De Weger RA; Garssen J; Los G; Askenase PW
Transplantation; 1989 Mar; 47(3):504-12. PubMed ID: 2466354
[TBL] [Abstract][Full Text] [Related]
37. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity.
Szczepanik M; Akahira-Azuma M; Bryniarski K; Tsuji RF; Kawikova I; Ptak W; Kiener C; Campos RA; Askenase PW
J Immunol; 2003 Dec; 171(11):6225-35. PubMed ID: 14634139
[TBL] [Abstract][Full Text] [Related]
38. Generation of effective antitumor vaccines using photodynamic therapy.
Gollnick SO; Vaughan L; Henderson BW
Cancer Res; 2002 Mar; 62(6):1604-8. PubMed ID: 11912128
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy-induced immunosuppression in humans is prevented by reducing the rate of light delivery.
Frost GA; Halliday GM; Damian DL
J Invest Dermatol; 2011 Apr; 131(4):962-8. PubMed ID: 21248771
[TBL] [Abstract][Full Text] [Related]
40. The antigen-bearing eye and the spleen are indispensable in maintaining anterior chamber-associated immune deviation.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):534-9. PubMed ID: 9040487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
